Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations
Nicolas H. Hart(University of Technology Sydney), Raymond J. Chan(Flinders University), Jasmine Yee(The University of Sydney), Gregory B. Crawford(The University of Adelaide), Fumiko Chino(The University of Texas MD Anderson Cancer Center), Bogda Koczwara(Flinders University), Thomas J. Smith(Sidney Kimmel Cancer Center), Andrea L. Smith(University of Michigan–Ann Arbor), Michael Jefford(The University of Melbourne), Michelle Mollica(National Cancer Institute), Meera Agar(University of Technology Sydney), Robin Zoň, Fredrick D. Ashbury(University of Calgary), Maryam B. Lustberg(Yale Cancer Center), Margaret I. Fitch(University of Toronto), Larissa Nekhlyudov(Brigham and Women's Hospital)
Cited by 39
Related Papers
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
|Journal of Clinical Oncology|2003|1.4k
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2009|913
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options
|Journal of Clinical Oncology|2015|903
Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update
|Journal of Clinical Oncology|2015|896
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
|Journal of Clinical Oncology|2016|654